Advertisement

Gambling Disorder: Future Perspectives in Research and Treatment

  • Nina Romanczuk-SeiferthEmail author
  • Marc N. Potenza
  • Andreas Heinz
Chapter

Abstract

The phenomenon of problem gambling is clearly a relevant public health concern. It is the first non-substance-use behavior formally recognized as a possible addiction by the American Psychiatric Association in DSM-5 in 2013 and is similarly discussed by the World Health Organization in ICD-11. For gambling-related problems, very serious negative consequences, especially in social, psychological, and financial domains, are common. The impact of gambling disorder extends beyond those with the disorder as family, friends, employers, and others are affected. Thus, gambling disorder is a significant mental health issue that unfortunately receives relatively rather limited attention compared with other disorders. Due to its relevance to society, gambling disorder should be of interest not only to physicians, psychologists, and other mental health care practitioners but also to government agencies. Therefore, it is important to understand how best to regulate gambling and prevent and treat gambling problems. Thus, this book chapter on future perspectives in research and treatment of gambling disorder focusses on important questions like why gambling phenomena require more attention, what needs to be reconsidered in classification and diagnostics, how to better understand the neurobiological mechanisms, and also how to advance prevention and treatment of gambling disorder in the future.

Keywords

Gambling disorder Pathological gambling Addiction Future 

References

  1. 1.
    Heinz A. A new understanding of mental disorders. Computational models for dimensional psychiatry. Cambridge, MA: MIT Press; 2017.CrossRefGoogle Scholar
  2. 2.
    Kessler RC, et al. DSM-IV pathological gambling in the national comorbidity survey replication. Psychol Med. 2008;38:1351–60.PubMedPubMedCentralGoogle Scholar
  3. 3.
    Petry NM, Stinson FS, Grant BF. Comorbidity of DSM-IV pathological gambling and other psychiatric disorders: results from the national epidemiologic survey on alcohol and related conditions. J Clin Psychiatry. 2005;66:564–74.CrossRefGoogle Scholar
  4. 4.
    Nature. Science has a gambling problem. Nature. 2018;553:379. http://www.nature.com/doifinder/10.1038/d41586-018-01051-z. Retrieved 6 Oct 2018.
  5. 5.
    Ladouceur R, Shaffer P, Blaszczynski A, Shaffer HJ. Responsible gambling: a synthesis of the empirical evidence. Addict Res Theory. 2017;25:225–35.CrossRefGoogle Scholar
  6. 6.
    Potenza MN, Higuchi S, Brand M. Call for research into a wider range of behavioural addictions. Nature. 2018;555:30.CrossRefGoogle Scholar
  7. 7.
    Petry NM. Should the scope of addictive behaviors be broadened to include pathological gambling? Addiction. 2006;101:152–60.CrossRefGoogle Scholar
  8. 8.
    Potenza MN. Should addictive disorders include non-substance-related conditions? Addiction. 2006;101:142–51.CrossRefGoogle Scholar
  9. 9.
    Psychiatry Online. Gambling disorder to be included in addictions chapter. Psychiatr News 2013;48:5. http://psychiatryonline.org/doi/abs/10.1176/appi.pn.2013.4b14. Retrieved 6 Oct 2018.
  10. 10.
    Romanczuk-Seiferth N, van den Brink W, Goudriaan AE. From symptoms to neurobiology: pathological gambling in the light of the new classification in DSM-5. Neuropsychobiology. 2014;70:95–102.CrossRefGoogle Scholar
  11. 11.
    Edwards G. Withdrawal symptoms and alcohol dependence: fruitful mysteries. Br J Addict. 1990;85:447–61.CrossRefGoogle Scholar
  12. 12.
    Korn DA, Shaffer HJ. Gambling and the health of the public: adopting a public health perspective. J Gambl Stud. 1999;15:289–365.CrossRefGoogle Scholar
  13. 13.
    Heinz A. Dopaminergic dysfunction in alcoholism and schizophrenia – psychopathological and behavioral correlates. Eur Psychiatry. 2002;17:9–16.CrossRefGoogle Scholar
  14. 14.
    Insel T, et al. Research domain criteria (RDoC): toward a new classification framework for research on mental disorders. Am J Psychiatry. 2010;167:748–51. http://psychiatryonline.org/doi/abs/10.1176/appi.ajp.2010.09091379. Retrieved 30 July 2018CrossRefGoogle Scholar
  15. 15.
    Balodis IM, et al. Diminished frontostriatal activity during processing of monetary rewards and losses in pathological gambling. Biol Psychiatry. 2012;71:749–57.CrossRefGoogle Scholar
  16. 16.
    Chase HW, Clark L. Gambling severity predicts midbrain response to near-miss outcomes. J Neurosci. 2010;30:6180–7.CrossRefGoogle Scholar
  17. 17.
    Genauck A, et al. Reduced loss aversion in pathological gambling and alcohol dependence is associated with differential alterations in amygdala and prefrontal functioning. Sci Rep. 2017;7:16306.CrossRefGoogle Scholar
  18. 18.
    Romanczuk-Seiferth N, Koehler S, Dreesen C, Wüstenberg T, Heinz A. Pathological gambling and alcohol dependence: neural disturbances in reward and loss avoidance processing. Addict Biol. 2015;20:557–69.CrossRefGoogle Scholar
  19. 19.
    Worhunsky PD, Malison RT, Rogers RD, Potenza MN. Altered neural correlates of reward and loss processing during simulated slot-machine fMRI in pathological gambling and cocaine dependence. Drug Alcohol Depend. 2014;145:77–86.CrossRefGoogle Scholar
  20. 20.
    Worhunsky PD, Potenza MN, Rogers RD. Alterations in functional brain networks associated with loss-chasing in gambling disorder and cocaine-use disorder. Drug Alcohol Depend. 2017;178:363–71.CrossRefGoogle Scholar
  21. 21.
    Deserno L, et al. Chonic alcohol intake abolishes the relationship between dopamine synthesis capacity and learning signals in the ventral striatum. Eur J Neurosci. 2015;41:477–86.CrossRefGoogle Scholar
  22. 22.
    Garbusow M, et al. Pavlovian-to-instrumental transfer effects in the nucleus accumbens relate to relapse in alcohol dependence. Addict Biol. 2016;21:719–31.CrossRefGoogle Scholar
  23. 23.
    Heinz A, et al. Targeted intervention: computational approaches to elucidate and predict relapse in alcoholism. Neuroimage. 2017;151:33–44.CrossRefGoogle Scholar
  24. 24.
    Nutt DJ, Lingford-Hughes A, Erritzoe D, Stokes PRA. The dopamine theory of addiction: 40 years of highs and lows. Nat Rev Neurosci. 2015;16:305–12.CrossRefGoogle Scholar
  25. 25.
    Potenza MN. How central is dopamine to pathological gambling or gambling disorder? Front Behav Neurosci. 2013;7:206.CrossRefGoogle Scholar
  26. 26.
    Potenza MN. Searching for replicable dopamine-related findings in gambling disorder. Biol Psychiatry. 2018;83:984–6.CrossRefGoogle Scholar
  27. 27.
    Xu J, et al. Large-scale functional network overlap is a general property of brain functional organization: reconciling inconsistent FMRI findings from general-linear-model-based analyses. Neurosci Biobehav Rev. 2016;71:83–100.CrossRefGoogle Scholar
  28. 28.
    Grant JE, et al. A proof of concept study of tolcapone for pathological gambling: relationships with COMT genotype and brain activation. Eur Neuropsychopharmacol. 2013;23:1587–96.CrossRefGoogle Scholar
  29. 29.
    Yang B-Z, Balodis IM, Lacadie CM, Xu J, Potenza MN. A preliminary study of DBH (encoding dopamine beta-hydroxylase) genetic variation and neural correlates of emotional and motivational processing in individuals with and without pathological gambling. J Behav Addict. 2016;5:282–92.CrossRefGoogle Scholar
  30. 30.
    Pereira LP, et al. Imaging genetics paradigms in depression research: systematic review and meta-analysis. Prog Neuropsychopharmacol Biol Psychiatry. 2018;86:102–13.CrossRefGoogle Scholar
  31. 31.
    Yip SW, Scheinhost D, Nich C, Potenza MN, Carroll KM. Connectome-based prediction of future cocaine abstinence. Am J Psychiatry. In press.Google Scholar
  32. 32.
    Friston KJ, Stephan KE, Montague R, Dolan RJ. Computational psychiatry: the brain as a phantastic organ. Lancet Psychiatry. 2014;1:148–58.CrossRefGoogle Scholar
  33. 33.
    Blaszczynski A, Nower L. A pathways model of problem and pathological gambling. Addiction. 2002;97:487–99.CrossRefGoogle Scholar
  34. 34.
    de Brito AMC, et al. Topiramate combined with cognitive restructuring for the treatment of gambling disorder: a two-center, randomized, double-blind clinical trial. J Gambl Stud. 2017;33:249–63.CrossRefGoogle Scholar
  35. 35.
    Grant JE, et al. A randomized, placebo-controlled trial of n-acetylcysteine plus imaginal desensitization for nicotine-dependent pathological gamblers. J Clin Psychiatry. 2014;75:39–45.CrossRefGoogle Scholar
  36. 36.
    The Guardian. Nasal spray aimed at tackling gambling addiction to be trialled in Finland | Science | The Guardian. 2018. https://www.theguardian.com/science/2018/jan/08/finnish-researchers-gambling-addiction-nasal-spray. Retrieved 6 Oct 2018.

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Nina Romanczuk-Seiferth
    • 1
    Email author
  • Marc N. Potenza
    • 2
    • 3
    • 4
  • Andreas Heinz
    • 1
  1. 1.Department of Psychiatry and PsychotherapyCharité—Universitätsmedizin BerlinBerlinGermany
  2. 2.Yale Center of Excellence in Gambling ResearchYale University School of MedicineNew HavenUSA
  3. 3.Women and Addictions Core of Women’s Health Research at YaleYale University School of MedicineNew HavenUSA
  4. 4.Yale University School of MedicineNew HavenUSA

Personalised recommendations